News

Walgreens partners with United Nations Foundation’s [email protected] campaign

BY Michael Johnsen

DEERFIELD, Ill. — Walgreens on Wednesday partnered with the United Nations Foundation to help provide up to 3 million vaccines during this flu season to children in developing countries through a donation to the Foundation’s [email protected] campaign.

Beginning Sept. 3 through Oct. 14, for every vaccine administered at any Walgreens pharmacy, Healthcare Clinic at select Walgreens or Duane Reade pharmacy in New York, Walgreens will donate the value of a vaccine, primarily those for polio and measles, through [email protected] for up to 3 million vaccines. 

"We’ve developed a number of innovative programs and public-private partnerships through which we’ve helped improve immunization rates in medically underserved areas, and among other targeted populations in need across the U.S.," stated Harry Leider, Walgreens chief medical officer. "With the growing need for life-saving vaccines such as polio and measles in developing countries, we’re proud to work with the UN Foundation on this important cause that provides access to vaccine for children in need, creates greater awareness and furthers our mission to help people get, stay and live well."

[email protected] is a movement to protect children worldwide by providing vaccines where they are needed most. The campaign is focused on educating and empowering Americans to support and advocate for decreasing vaccine-preventable childhood deaths while giving children around the world a shot at a healthy life.

The collaboration with [email protected] builds upon Walgreens’ national and international efforts to provide greater access to healthcare services. Over the last two years, Walgreens has worked with the Centers for Disease Control and Prevention and the World Health Organization to donate more than 400,000 doses of flu vaccine for at-risk populations in Laos and Nicaragua. In the United States, Walgreens is in its fourth year of a flu shot voucher program developed in conjunction with the U.S. Department of Health and Human Services. Through that program, Walgreens has distributed approximately 1 million flu shot vouchers to uninsured and underinsured individuals nationwide.

Correction: An earlier version of this article stated the incorrect start date. We apologize for the error.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

IRI acquires Aztec from Aegis Media

BY Michael Johnsen

CHICAGO  — IRI announced it has acquired Aztec, a provider of market measurement and related services for consumer packaged goods, liquor and pharmaceutical manufacturers and retailers in Australia, Canada, Hong Kong, New Zealand, South Africa, Sweden and the United Kingdom. Aztec was acquired from Aegis Media.

“This agreement directly supports our overarching ‘Growth Delivered’ business strategy and underscores IRI’s ongoing commitment to expanding its geographic footprint and capabilities to meet our multi-country clients’ evolving research needs,” stated Andrew Appel, president and CEO, IRI. “Aztec is a recognized leader in its markets and offers a host of distinctive assets, tools and relationships, including highly-differentiated offerings in the wholesaler and convenience sectors. This partnership immediately delivers a significant step change in value through an expanded presence, complementing IRI’s existing capabilities in the eight countries it currently serves.”

“Combining our complementary strengths with Aztec’s furthers IRI’s position as an innovation and market leader in all the markets it serves by offering enhanced data, combined with superior advanced analytics, consumer and shopper marketing, and consulting services to increase the pace of growth for each entity’s clients,” Appel added.

Aztec includes six service lines: CRM, scan data sourcing, data processing, market measurement, shopper insights, and advanced analytics. The company, which was founded in 1995, has more than 500 employees and was previously part of Aegis Media, a global media and digital communications specialist.


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

C&D on hunt for next blockbuster acquisition opportunity

BY Michael Johnsen

BOSTON — Church & Dwight is on the hunt for its next acquisition, after having successfully integrated its gummy vitamin line from Avid Health, chairman and CEO James Craigie told analysts at the 2013 Barclays Back-to-School Consumer Conference held here Tuesday. 

And C&D may be as few as three years away from fielding an OTC product in a gummy format. 

"I sometimes think, honestly, acquisition is one of the greatest strengths for my company," Craigie said. "We will only buy a No. 1 or 2 share brand [and] we want brands that are higher growth, higher margins," he said. C&D is also patient, Craigie said. "We waited two-and-a-half years for our Avid acquisition since our last big acquisition [before that], which was Orajel."

Regarding the Avid Health line of gummy vitamins, Craigie continues to be bullish. "Here is a $7 billion category with consistent strong growth [with] 57% of adults using nutritional supplements," he said. "And with the aging trends and the healthcare trends this will continue to grow very strong."

Church & Dwight fields the No. 1 kids vitamin brand in L’il Critters, which fields a 64% marketshare, Craigie said. And while its adult line, Vitafusion, only has a 5% share, the adult opportunity is much greater. "The kids business is wonderful but the adult business, the category is 20 times the size of the kids business," he said. "The adult side [of gummy vitamins] is growing at 57% in the recent time period."

Overall, sales of vitamins are up 7%, Craigie noted. Avid Health products are outpacing that with 34% growth in the past year. 

Beyond gummy vitamins, there may be an opportunity within gummy OTCs, Craigie added. "Why can’t we take the gummy form and go to other OTC categories that are out there — aspirin, cough and cold, allergies … especially for kids," he said. "That’s not easy to do, we have to mask the bad flavors in many situations, we have to keep the active ingredient inside the product," he acknowledged. "But we see that as a good opportunity which we hopefully can start to leverage three or five years from now."


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES